Neurovascular Intervention Market

Global Neurovascular Intervention Market reached $1.5 billion in 2012. The market, which is still experiencing double digit growth is expected to surpass $2.5 billion by 2018.

Stryker continued to consolidate its leading position in the neurovascular space by acquiring  Concentric Medical in the fourth quarter of 2011 and Surpass Medical in fourth quarter of 2012; each for $135 million in cash.

In January 2012 Covidien bought Reverse Medical’s neurovascular guide catheter business and Terumo acquired Onset Medical access sheath technology.

The addition of carotid stent systems to within the neurovascular boundaries coupled with continued consolidation in the space have transformed the strategic landscape of the market which is expected to continue to offer lucrative acquisition opportunities for leading participants and high valuation for innovative startups.

Neurovascular Intervention Market Report analyzes revenue and growth trends for the entire sector with special emphasis on embolic coils, intracranial stents, liquid embolics, carotid stents and thrombectomy devices.

The report, which segments the market based on disease areas with special emphasis on cerebral aneurysm and both acute and chronic cerebral ischemia offers answers to many important questions including:

How does the new neurovascular landscape look like? How have market shares been redistributed? What are current growth trends? How will the market evolve in the near future? What are the current critical success factors? and last, but not least, what are the current valuation levels for new technologies and innovative start-ups venturing into the space.

Neurovascular Intervention Market Report is targeted at senior executives in the medical device industry who wish to get up-to-date with this multi-billion dollar fast growing market and offers an updated linear forecast to 2018.

Published: May 2013 - Number of Pages: #75 Pages - PDF by eMail


Table of Contents

1.         Executive Summary

2.         Global Neurovascular Intervention Market

2.1       Market Revenue & Growth Trend
2.2       Hemorrhagic Stroke Market
2.3       Ischemic Stroke Market
2.4       Top Five Neurovascular Intervention Companies
2.4.1     Stryker
2.4.2     Covidien
2.4.3     Johnson & Johnson
2.4.4     Abbott Vascular
2.4.5     Terumo
2.5        Leading Companies Market Shares
2.6        Other Companies in the Space
2.6.1     Balt Extrusion
2.6.2     B. Braun
2.6.3     Boston Scientific
2.6.4     Cardiatis
2.6.5     Cerus Endovascular
2.6.6     Chestnut Medical
2.6.7     CoAxia
2.6.8     Codman Neurovascular
2.6.9     Concentric Medical
2.6.10   DePuy
2.6.11   ev3
2.6.12   Flexible Stenting Solutions
2.6.13   Gore Medical
2.6.14   ITGI Medical
2.6.15   Merlin MD
2.6.16   MicroVention
2.6.17   Micrus Endovascular
2.6.18   MindFrame
2.6.19   NeuroVasx
2.6.20   Nfocus Neuromedical
2.6.21   Penumbra
2.6.22   Phenox GmbH
2.6.23   Reverse Medical
2.6.24   Sequent Medical
2.6.25   Surpass Medical
2.6.26   Valor Medical

3.    Geographic Segmentation

3.1    US Neurovascular Intervention Market
3.2    European Neurovascular Intervention Market
3.3    Japanese Neurovascular Intervention Market

4.    Disease Area Segmentation

4.1    Endovascular Cerebral Aneurysm Repair Market

4.1.1    Cerebral Aneurysm
4.1.2    Natural History and Demographics
4.1.3    Surgical Repair of Cerebral Aneurysms (Clipping)
4.1.5    Endovascular Repair of Cerebral Aneurysms(Coiling)
4.1.6    Balloon Assisted Coiling
4.1.7    Stent Assisted Coiling
4.1.8    Polymer Embolics
4.1.9    Hemodynamic Repair of Cerebral Aneurysms

4.2    Acute Ischemic Stroke (AIS) Market

4.2.1    Medical Management of AIS
4.2.2    Thrombectomy and Clot Retrieval

4.3    Intracranial Atherosclerotic Disease (ICAD) Market

4.3.1    Medical Management of ICAD
4.3.2    Surgical Revascularization
4.3.4    Intracranial Angioplasty & Stenting

5.    Device Category Segmentation

5.1    Neurovascular Embolic Coils Market

5.1.1    Market Overview & Growth Trend
5.1.2    Trend in Use in Ruptured & Un-ruptured Aneurysms
5.1.3    Leading Companies & Their Products
5.1.4    Bare Metal, Coated and Bio-Active Coils
5.1.5    Geographic Segmentation
5.1.6    Leading Companies Market Shares

5.2    Neurovascular Liquid Embolics Market

5.2.1    Market Overview & Growth Trend
5.2.2    Arterio Venous Malformations (AVMs)
5.2.3    Leading Companies & Their Products
5.2.4    Leading Companies Market Shares

5.3    Intracranial Stents & Flow Diverting Devices Market

5.3.1    Market Overview & Growth Trend
5.3.2    Cerebral Aneurysm Stents Market
5.3.3    Assisted Coil Insertion Stents Market
5.3.4    Flow Diverting Devices Market
5.3.5    Cerebral Ischemia Stents Market
5.3.6    Geographic Segmentation
5.3.7    Leading Companies Market Shares

5.4    Neurovascular Thrombectomy Device Market

5.4.1    Market Overview & Growth Trend
5.4.2    Leading Companies & Their Products
5.4.3    Geographic Segmentation
5.4.4    Leading Companies Market Shares

5.5    Carotid Stents & Embolic Protection Devices Market

5.5.1    Market Overview & Growth Trend
5.5.2    Leading Companies & Their Products
5.5.3    Geographic Segmentation
5.5.4    Leading Companies Market Shares

6.       Valuation in the Neurovascular Space

6.1     ev3 Chestnut Medical Deal
6.2     Covidien ev3 Deal
6.3     DePuy Micrus Endovascular Deal
6.4     Stryker Boston Scientific Deal
6.5     Stryker Concentric Medical Deal
6.6     Stryker Surpass Medical Deal

7.    Future Outlook

7.1    Market Drivers
7.2    Technological Trends
7.3    Market Forecast

Tables & Figures

1.    Neurovascular Intervention Market – Revenue & Growth Rates (2007 – 2012)
2.      Neurovascular Intervention Market – Geographic Segmentation (2012)
3.      Neurovascular Intervention Market – Disease Area Segmentation (2012)
4.      Neurovascular Intervention Market – Device Category Segmentation (2012)
5.      Neurovascular Intervention Market – Leading Companies Market Shares (2012)
6.      Covidien Neurovascular Business Unit Revenue (2007 – 2012)
7.      Stryker Neurovascular Business Unit Revenue (2007 – 2012)
8.      Terumo Neurovascular Business Unit Revenue (2007 – 2012)
9.      Neurovascular Coils Market – Revenue & Growth Rates (2007 – 2012)
10.    Neurovascular Coils Market – Geographic Segmentation (2012)
11.    Neurovascular Coils Market – Disease Area Segmentation (2012)
12.    Neurovascular Coils Market – Device Category Segmentation (2012)
13.    Neurovascular Coils Market – Leading Companies Market Shares (2012)
14.    Intracranial Stents Market – Revenue & Growth Rates (2007 – 2012)
15.    Intracranial Stents Market – Geographic Segmentation (2012)
16.    Intracranial Stents Market – Device Category Segmentation (2012)
17.    Intracranial Stents Market – Leading Companies Market Shares (2012)
18.    Liquid Embolics Systems Market – Revenue & Growth Rates (2007 – 2012)
19.    Liquid Embolics Systems Market – Leading Companies Market Shares (2012)
20.    Neurovascular Thrombectomy Market – Revenue & Growth Rates (2007 – 2012)
21.    Neurovascular Thrombectomy Market – Geographic Segmentation (2012)
22.    Neurovascular Thrombectomy Market – Leading Companies Market Shares (2012)
23.    Carotid Stents Market – Revenue & Growth Rates (2007 – 2012)
24.    Carotid Stents Market – Geographic Segmentation (2012)
25.    Carotid Stents Market – Leading Companies Market Shares (2012)
26.    US Neurovascular Intervention Market – Revenue & Growth Rates (2007 – 2012)
27.    US Neurovascular Intervention Market – Device Category Segmentation (2012)
28.    US Neurovascular Intervention Market – Companies Market Shares (2012)
29.    EU Neurovascular Intervention Revenue & Growth Rates (2007 – 2012)
30.    EU Neurovascular Intervention Market – Device Category Segmentation (2012)
31.    EU Neurovascular Intervention Market – Companies Market Shares (2012)
32.    Japan Neurovascular Intervention Revenue & Growth Rates (2007 – 2012)
33.    Japan Neurovascular Intervention – Device Category Segmentation (2012)
34.    Japan Neurovascular Intervention Market – Companies Market Shares (2012)
35.    Neurovascular Intervention Market Forecast (2013 – 2018)